
Astria Therapeutics Grants Inducement Awards Pursuant to Nasdaq Rule 5635(c)(4)
Astria Therapeutics Grants Stock Options to New Employees Under Nasdaq Listing Rule 5635(c)(4) Astria Therapeutics, Inc. (Nasdaq: ATXS), a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for allergic and immunologic diseases, has announced the granting of stock options to…












